By using a well-designed epidemiologic database (North American Pancreatitis Study 2), the authors show that a highly significant difference in susceptibility to fibrosis exists with CTRC variants, but not for patients suffering from RAP.
1
—
—
By using a well-designed epidemiologic database (North American Pancreatitis Study 2), the authors show that a highly significant difference in susceptibility to fibrosis exists with CTRC variants, but not for patients suffering from RAP.